Experimental Treatment of Prostatic Cancer by Intermittent Hormonal Therapy-Reference-Cited by-同舟云学术

Experimental Treatment of Prostatic Cancer by Intermittent Hormonal Therapy

Published:1987-04 Issue:4 Volume:137 Page:785-788
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Trachtenberg John¹

Affiliation:

1. From the Department of Surgery/Urology, The University of Toronto, Toronto, Ontario, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference13 articles.

1. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res.,1941

2. Survival following castration for prostatic cancer;Vest;J. Urol.,1946

3. Veterans Administration Cooperative Urological Research Group: Treatment and survival of patients with cancer of the prostate;Surg. Gynecol. Obstet.,1967

4. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy;Sogani;Cancer,1983

5. The Leuprolide Study Group: Leuprolide vrs DES in the initial therapy of advanced prostatic cancer.: A randomized prospective trial;N. Engl. J. Med.,1984

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermittent ADT for Prostate Cancer;Hormone Therapy and Castration Resistance of Prostate Cancer;2018

2. Intermittent hormone therapy versus continuous hormone therapy for locally advanced prostate cancer: a meta-analysis;The Aging Male;2015-07-30

3. Intermittent versus Continuous Androgen Deprivation in Prostate Cancer;New England Journal of Medicine;2013-04-04

4. Die intermittierende Androgenblockade beim fortgeschrittenen Prostatakarzinom - eine Übersicht;Aktuelle Urologie;2012-01-05

5. Intermittent androgen suppression for prostate cancer;Nature Reviews Urology;2010-09-14